Performance of pneumococcal urinary antigen test in patients with community-onset pneumonia: a propensity score-matching study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims:Although pneumococcal urinary antigen tests (PUATs) have universally been used for the diagnosis of pneumococcal pneumonia, data on the efficacy of these exams are limited. The objective of our study was to investigate the clinical impact of the PUAT in patients with community-onset pneumonia (CO-pneumonia). Methods: We conducted a retrospective cohort study of patients diagnosed with CO-pneumonia. Patients were classified according to their PUAT results and were matched using the propensity score-matching method. The primary outcome was 30-day mortality. Results: A total of 1,257 patients were identified and 163 (13.0%) demonstrated positive PUAT results. The sensitivity and specificity values of PUAT for overall pneumococcal pneumonia were 56.5% and 91.4%, respectively. In the full cohort, there were no significant differences in 30-day mortality between the two groups (6.1% in the positive PUAT group vs. 8.2% in the negative PUAT group, p = 0.357). However, in the propensity-matched cohort, the 30-day mortality rates were lower in the positive PUAT group (5.6% vs. 17.4%, p = 0.001). With respect to secondary outcomes, the proportion of patients with potentially drug-resistant pathogens, changes in antibiotics, and failure rates of initial antibiotic therapy were significantly lower in the positive PUAT group than in the negative PUAT group of the propensity-matched cohort. Conclusions:We found that the sensitivity of the index test was low and specificity was high in this clinical setting. And our findings suggest that positive PUAT results may be associated with favorable clinical outcomes in patients with CO-pneumonia.
Abstract
Background/Aims:Although pneumococcal urinary antigen tests (PUATs) have universally been used for the diagnosis of pneumococcal pneumonia, data on the efficacy of these exams are limited. The objective of our study was to investigate the clinical impact of the PUAT in patients with community-onset pneumonia (CO-pneumonia). Methods: We conducted a retrospective cohort study of patients diagnosed with CO-pneumonia. Patients were classified according to their PUAT results and were matched using the propensity score-matching method. The primary outcome was 30-day mortality. Results: A total of 1,257 patients were identified and 163 (13.0%) demonstrated positive PUAT results. The sensitivity and specificity values of PUAT for overall pneumococcal pneumonia were 56.5% and 91.4%, respectively. In the full cohort, there were no significant differences in 30-day mortality between the two groups (6.1% in the positive PUAT group vs. 8.2% in the negative PUAT group, p = 0.357). However, in the propensity-matched cohort, the 30-day mortality rates were lower in the positive PUAT group (5.6% vs. 17.4%, p = 0.001). With respect to secondary outcomes, the proportion of patients with potentially drug-resistant pathogens, changes in antibiotics, and failure rates of initial antibiotic therapy were significantly lower in the positive PUAT group than in the negative PUAT group of the propensity-matched cohort. Conclusions:We found that the sensitivity of the index test was low and specificity was high in this clinical setting. And our findings suggest that positive PUAT results may be associated with favorable clinical outcomes in patients with CO-pneumonia.
참고문헌 (36)
- Zar HJ, "Pneumonia in low and middle incomecountries : progress and challenges", Thorax, 68, pp.1052~1056 (2013)
- Musher DM, "Community-acquired pneumonia", N Engl J Med, 371, pp.1619~1628 (2014)
- Mandell LA, "Infectious Diseases Society of America", American Thoracic Society consensus guidelines on themanagement of community-acquired pneumonia in adults, 2007, pp.44, S27~S72
- van der Eerden MM, "Comparison between pathogen directed antibiotic treatment andempirical broad spectrum antibiotic treatment in patients with community acquired pneumonia : a prospective randomised study", Thorax, 60, pp.672~678 (2005)
- Garcia-Vazquez E, "Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system", Arch Intern Med, 164, pp.1807~1811 (2004)
- Campbell SG, "The contribution of blood cultures to the clinical management of adult patients admitted to the hospital with community-acquired pneumonia : a prospective observational study", Chest, 123, pp.1142~1150 (2003)
- Molinos L, "Sensitivity, specificity, and positivity predictors of the pneumococcal urinary antigen testin community-acquired pneumonia", Ann Am Thorac Soc, 12, pp.1482~1489 (2015)
- Smith MD, "Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test : a prospective, controlled clinical evaluation", J Clin Microbiol, 41, pp.2810~2813 (2003)
- Lim WS, "BTS guidelines for themanagement of community acquired pneumonia in adults : update 2009", Thorax, 64, pp.iii1~iii55 (2009)
- West DM, "Pneumococcal urinary antigen test use in diagnosis and treatment of pneumonia in seven Utah hospitals", ERJ Open Res, 2, pp.000112016~ (2016)
- Dean NC, "Impact of an electronic clinical decision support tool for emergency department patients with pneumonia", Ann Emerg Med, 66, pp.511~520 (2015)
- Kalil AC, "Management of adults with hospital-acquired and ventilator-associated pneumonia : 2016 clinical practice guidelines by the Infectious Diseases Society of Americaand the American Thoracic Society", Clin Infect Dis, 63, pp.e61~e111 (2016)
- Shindo Y, "Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital", Chest, 135, pp.633~640 (2009)
- Micek ST, "Healthcare-associated pneumonia and community-acquired pneumonia : a single-centerexperience", Antimicrob Agents Chemother, 51, pp.3568~3573 (2007)
- Yamagishi Y, "A retrospective study of health care-associatedpneumonia patients at Aichi Medical University hospital", J Infect Chemother, 17, pp.756~763 (2011)
- American Thoracic Society, "Guidelinesfor the management of adults with hospital-acquired, ventilator-associated, andhealthcare-associated pneumonia", Am J Respir Crit Care Med, 171, pp.388~416 (2005)
- Sorde R, "Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia toguide antimicrobial therapy", Arch Intern Med, 171, pp.166~172 (2011)
- Deeks JJ, "Diagnostic tests 4 : likelihood ratios", BMJ, 329, pp.168~169 (2004)
- Gadsby NJ, "Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia", Clin Infect Dis, 62, pp.817~823 (2016)
- Johansson N, "Etiology ofcommunity-acquired pneumonia : increased microbiological yield with new diagnostic methods", Clin Infect Dis, 50, pp.202~209 (2010)
- Postma DF, "Antibiotic treatment strategies for community-acquired pneumonia in adults", N Engl J Med, 372, pp.1312~1323 (2015)
- Jain S, "Community-acquired pneumonia requiring hospitalization", N Engl J Med, 373, pp.2382~ (2015)
- Webb BJ, "Predicting risk of drug-resistant organisms in pneumonia : moving beyond the HCAP model", Respir Med, 109, pp.1~10 (2015)
- Horita N, "Sensitivity and specificity of the Streptococcus pneumoniae urinary antigen test for unconcentrated urine from adult patients with pneumonia : a meta-analysis", Respirology, 18, pp.1177~1183 (2013)
- Roson B, "Contribution of a urinary antigen assay(Binax NOW)to the earlydiagnosis of pneumococcal pneumonia", Clin Infect Dis, 38, pp.222~226 (2004)
- Zalacain R, "Streptococcus pneumoniae antigen in urine : diagnostic usefulness and impact on outcome of bacteraemic pneumococcal pneumonia in a large series of adultpatients", Respirology, 19, pp.936~943 (2014)
- Kim B, "Prognostic value of pneumococcal urinary antigen test in community-acquired pneumonia", PLoS One, 13, pp.e0200620~ (2018)
- Guchev IA, "Management of nonsevere pneumonia in military trainees with the urinary antigentest for Streptococcus pneumoniae : an innovative approach to targeted therapy", Clin Infect Dis, 40, pp.1608~1616 (2005)
- Falguera M, "Prospective, randomised study to compare empirical treatment versustargeted treatment on the basis of the urine antigen results in hospitalized patients with community-acquired pneumonia", Thorax, 65, pp.101~106 (2010)
- 김선주, "한 대학병원에서 폐렴구균 소변항원검사 양성 결과의 분석", Annals of Clinical Microbiology, 13(1), pp.14~18 (2010), 대한임상미생물학회
- del Mar Garcia-Suarez M, "Performance of a pneumolysin enzyme-linked immunosorbent assay for diagnosis of pneumococcal infections", J Clin Microbiol, 45, pp.3549~3554 (2007)
- Tleyjeh IM, "The impact ofpenicillin resistance on short-term mortality in hospitalized adults withpneumococcal pneumonia : a systematic review and meta-analysis", Clin Infect Dis, 42, pp.788~797 (2006)
- McCabe C, "Guideline-concordanttherapy and reduced mortality and length of stay in adults with community-acquired pneumonia : playing by the rules", Arch Intern Med, 169, pp.1525~1531 (2009)
- Salinas-Botran A, "Positive urine pneumococcal antigen test and vaccination", Med Clin(Barc), 146, pp.346~347 (2016)
- Jain S, "Community-acquired pneumonia requiring hospitalization among U. S. adults", N Engl J Med, 373, pp.415~427 (2015)
- Weinberger DM, "Association of serotype with risk of death due to pneumococcal pneumonia : ameta-analysis", Clin Infect Dis, 51, pp.692~699 (2010)